| Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial FX Pi-Sunyer, LJ Aronne, HM Heshmati, J Devin, J Rosenstock, ... Jama 295 (7), 761-775, 2006 | 1610 | 2006 |
| Pharmacological management of obesity: an endocrine Society clinical practice guideline CM Apovian, LJ Aronne, DH Bessesen, ME McDonnell, MH Murad, ... The Journal of Clinical Endocrinology & Metabolism 100 (2), 342-362, 2015 | 1426 | 2015 |
| Tirzepatide once weekly for the treatment of obesity AM Jastreboff, LJ Aronne, NN Ahmad, S Wharton, L Connery, B Alves, ... New England Journal of Medicine 387 (3), 205-216, 2022 | 1070 | 2022 |
| Obesity‐related hypertension: Pathogenesis, cardiovascular risk, and treatment—A position paper of the The Obesity Society and the American Society of Hypertension L Landsberg, LJ Aronne, LJ Beilin, V Burke, LI Igel, D Lloyd‐Jones, ... Obesity 21 (1), 8-24, 2013 | 977 | 2013 |
| Ten putative contributors to the obesity epidemic EJ McAllister, NV Dhurandhar, SW Keith, LJ Aronne, J Barger, M Baskin, ... Critical reviews in food science and nutrition 49 (10), 868-913, 2009 | 928 | 2009 |
| Putative contributors to the secular increase in obesity: exploring the roads less traveled SW Keith, DT Redden, PT Katzmarzyk, MM Boggiano, EC Hanlon, ... International journal of obesity 30 (11), 1585-1594, 2006 | 860 | 2006 |
| Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: the SCALE Maintenance randomized study TA Wadden, P Hollander, S Klein, K Niswender, V Woo, PM Hale, ... International journal of obesity 37 (11), 1443-1451, 2013 | 821 | 2013 |
| Joint international consensus statement for ending stigma of obesity F Rubino, RM Puhl, DE Cummings, RH Eckel, DH Ryan, JI Mechanick, ... Nature medicine 26 (4), 485-497, 2020 | 782 | 2020 |
| Causes of obesity SM Wright, LJ Aronne Abdominal Radiology 37, 730-732, 2012 | 711 | 2012 |
| A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity‐related risk factors (COR‐II) CM Apovian, L Aronne, D Rubino, C Still, H Wyatt, C Burns, D Kim, ... Obesity 21 (5), 935-943, 2013 | 643 | 2013 |
| Obesity, adiposity, and dyslipidemia: a consensus statement from the National Lipid Association HE Bays, PP Toth, PM Kris-Etherton, N Abate, LJ Aronne, WV Brown, ... Journal of clinical lipidology 7 (4), 304-383, 2013 | 606 | 2013 |
| Classification of obesity and assessment of obesity‐related health risks LJ Aronne Obesity research 10 (S12), 105S-115S, 2002 | 500 | 2002 |
| Orlistat, a lipase inhibitor, for weight maintenance after conventional dieting: a 1-y study JO Hill, J Hauptman, JW Anderson, K Fujioka, PM O'Neil, DK Smith, ... The American journal of clinical nutrition 69 (6), 1108-1116, 1999 | 403 | 1999 |
| Effect of liraglutide 3.0 mg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE Sleep Apnea randomized clinical trial A Blackman, GD Foster, G Zammit, R Rosenberg, L Aronne, T Wadden, ... International journal of obesity 40 (8), 1310-1319, 2016 | 385 | 2016 |
| Effect of orlistat in overweight and obese patients with type 2 diabetes treated with metformin JM Miles, L Leiter, P Hollander, T Wadden, JW Anderson, M Doyle, ... Diabetes care 25 (7), 1123-1128, 2002 | 383 | 2002 |
| Adiposity and fat distribution outcome measures: assessment and clinical implications LJ Aronne, KR Segal Obesity 10 (s11), 14S, 2002 | 238 | 2002 |
| Epidemiology, morbidity, and treatment of overweight and obesity LJ Aronne Journal of Clinical Psychiatry 62, 13-22, 2001 | 235 | 2001 |
| The emerging science of body weight regulation and its impact on obesity treatment J Korner, LJ Aronne The Journal of clinical investigation 111 (5), 565-570, 2003 | 231 | 2003 |
| Evaluation of phentermine and topiramate versus phentermine/topiramate extended‐release in obese adults LJ Aronne, TA Wadden, C Peterson, D Winslow, S Odeh, KM Gadde Obesity 21 (11), 2163-2171, 2013 | 229 | 2013 |
| Endoscopic sleeve gastroplasty significantly reduces body mass index and metabolic complications in obese patients RZ Sharaiha, NA Kumta, M Saumoy, AP Desai, AM Sarkisian, ... Clinical Gastroenterology and Hepatology 15 (4), 504-510, 2017 | 222 | 2017 |
